NCT04682067View on ClinicalTrials.gov

Diabetes Smoking Cessation Incentives Study

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

April 7, 2022

Study Completion Date

April 7, 2022

Conditions
Smoking CessationDiabetes Type 2
Interventions
BEHAVIORAL

Contingency Management

Escalating financial incentives contingent upon biochemical evidence of abstinence

BEHAVIORAL

Usual Care smoking cessation

Usual care smoking cessation support

Trial Locations (1)

73104

Oklahoma Tobacco Research Center, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT04682067 - Diabetes Smoking Cessation Incentives Study | Biotech Hunter | Biotech Hunter